Actar - Collaborating for success

Actar is a drug discovery company based on the Karolinska Institutet campus in Stockholm, Sweden. The company is a part of the Karolinska Institutet´s innovation system.

Actar explores innovative drug targets in multiple therapeutic areas resulting from academic research at top European institutions. Actar collaborates with the academic researchers to perform drug discovery based on these targets. Aiming to discover proprietary compounds with validated effect in relevant disease models, Actar brings its expertise in drug research and project management together with therapeutic area competency of the academic researchers. Drug-like compounds active against these targets are identified, characterized and divested, or further developed in collaboration with larger pharmaceutical companies.

Classified as a small/medium size Swedish biotechnology company, Actar has engaged in EU’s seventh research framework programme (FP7). Actar has set up strategic alliances and company-company collaborations, and is active in building up business networks focused on early development of academic research.